BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8427051)

  • 1. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone.
    Murray TM; Rao LG; Wong MM; Waddell JP; McBroom R; Tam CS; Rosen F; Levine MA
    J Bone Miner Res; 1993 Jan; 8(1):83-91. PubMed ID: 8427051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal-nonresponsive, bone-responsive pseudohypoparathyroidism. A case with normal vitamin D metabolite levels and clinical features of rickets.
    Dabbagh S; Chesney RW; Langer LO; DeLuca HF; Gilbert EF; DeWeerd JH
    Am J Dis Child; 1984 Nov; 138(11):1030-3. PubMed ID: 6548601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells.
    Wong MM; Rao LG; Ly H; Hamilton L; Tong J; Sturtridge W; McBroom R; Aubin JE; Murray TM
    J Bone Miner Res; 1990 Aug; 5(8):803-13. PubMed ID: 2173356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis.
    Eubanks PJ; Stabile BE
    Arch Surg; 1998 Jun; 133(6):673-6. PubMed ID: 9637471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 1,25-dihydroxyvitamin D3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells.
    Pols HA; Schilte HP; Herrmann-Erlee NM; Visser TJ; Birkenhäger JC
    Bone Miner; 1986 Oct; 1(5):397-405. PubMed ID: 2849488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type I pseudohypoparathyroidism. Study and prolonged follow-up of a case].
    Pardos LC; Buñuel C; Antón R; García C; Lasarte JJ; Mayayo E; Ferrández A
    An Esp Pediatr; 1989 Sep; 31(3):240-7. PubMed ID: 2631607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis.
    Parfitt AM
    Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteitis fibrosa cystica von Recklinghausen].
    Røkke O; Due J; Dale K
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):960-1. PubMed ID: 2321226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptors.
    Katz MS; Gutierrez GE; Mundy GR; Hymer TK; Caulfield MP; McKee RL
    J Cell Physiol; 1992 Oct; 153(1):206-13. PubMed ID: 1325978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct effect of calcitriol on the regulation of parathyroid hormone secretion in a case of pseudo-hypoparathyroidism (a 24-month follow-up study).
    Giraud P; Audran M; Rohmer V; Jallet P; Basle MF; Bregeon C; Bigorgne JC
    Clin Rheumatol; 1995 May; 14(3):287-91. PubMed ID: 7641504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
    Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
    Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked direct suppression of primary hyperparathyroidism with osteitis fibrosa cystica by intravenous administration of 1,25-dihydroxycholecalciferol.
    Patron P; Gardin JP; Borensztein P; Prigent A; Paillard M
    Miner Electrolyte Metab; 1989; 15(6):321-5. PubMed ID: 2615719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that pulsed electromagnetic fields inhibit coupling of adenylate cyclase by parathyroid hormone in bone cells.
    Cain CD; Adey WR; Luben RA
    J Bone Miner Res; 1987 Oct; 2(5):437-41. PubMed ID: 3455626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.